• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carilion Clinic further expands quality cardiac care access with latest Philips innovations at new regional cardiovascular institute in Virginia, US

    8/20/24 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care
    Get the next $PHG alert in real time by email

    August 20, 2024

    • Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes
    • New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home

    Amsterdam, The Netherlands and Roanoke, US – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, and Carilion Clinic, a not-for-profit health care organization serving more than one million people in the States of Virginia and West Virginia, today announced Carilion will adopt the Philips cardiovascular care ecosystem of solutions at the future home of its Cardiovascular Institute at Crystal Spring Tower. Carilion's new facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home while optimizing the clinical, operational and overall performance of the health system's cardiovascular service line. This investment illustrates Carilion's commitment to empowering its clinicians with innovative technology to provide quality care for its communities.

    Carilion's comprehensive hospital network, primary and specialty physician practices and other complementary services deliver high-quality, patient-centered care. The flagship hospital, Carilion Roanoke Memorial Hospital, totals 718 beds. The Carilion Clinic Cardiovascular Institute will relocate to this new facility and provide state-of-the art heart, lung and vascular services to the region. Services include inpatient nursing care, cardiovascular ORs, cardiac catheterization and electrophysiology labs.

    Along with caring for the local community, Carilion Roanoke Memorial Hospital is the major referral center and only Level 1 Trauma Center for patients in the region who require specialized medical care. It also has the only hybrid operating rooms available in Southwest Virginia. Equipped with these new Philips solutions, the highly skilled medical staff will be able to continue handling complex cases or procedures that may not be available at surrounding healthcare facilities.

    "At Carilion Clinic, we are committed to improving the health of the communities we serve. We know that collaboration is an essential component to realizing this vision," said Marguerite Underwood, Vice President for the Carilion Clinic Cardiovascular Institute. "Working with Philips ensures that we will be able to set the standard in cardiovascular care, not only today, but well into the future."

    The new labs are the foundation of the integrated Philips ecosystem of solutions for cardiovascular care and include the Philips Azurion Image-Guided Therapy System, along with EPIQ CVx cardiology ultrasound system with ultrasound enabled AI capabilities, IntraSight with SyncVision for IVUS imaging and physiology and interventional tools. Together, the technology provides exceptional imaging with reduced X-ray dose [1], improved workflow and more efficient turnaround times [2], offering a high level of clinical confidence. A service program will reduce maintenance complexity, keeping systems up to date with the latest software. Furthermore, Carilion will be able to leverage ongoing clinical education for its staff.

    "For many years, Carilion has been recognized for delivering exceptional cardiac care. Maintaining the highest standard of care means continuous growth and innovation, making healthcare delivery more efficient and effective," said Jeff DiLullo, Chief Region Leader, Philips North America. "The Crystal Spring Tower expansion illustrates Carilion's commitment to its staff and patients, giving clinicians access to world-class technology while providing a level of care not available anywhere else in the region."

    [1] In 37 individual comparative studies, Philips ClarityIQ was associated with reductions in patient radiation exposure. The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional radiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task.

    [2] Results from study conducted at St. Antonius Hospital. Results verified by NAMSA, independent third-party expert on study design and analytics. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.

    For more information:





    Avi Dines

    Philips North America

    Tel: +1 781 690 3814

    Email: [email protected]

    Joost Maltha

    Philips Global External Relations

    Tel: +31 6 10 55 8116

    Email: [email protected]

    About Royal Philips

    Royal Philips (NYSE:PHG, AEX: PHIA))) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

    Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

    About Carilion Clinic's Cardiovascular Institute (CVI)

    As southwest Virginia's cardiovascular care leader, our award-winning team combines continuous research and the latest technological advances with patient-centered care to ensure better surgical outcomes, fewer complications and faster recovery times.

    With almost 800 members, the CVI team offers expert care across the cardiovascular spectrum, from medical, surgical, pre- and post-operative, rehab therapies, imaging and beyond. Moreover, our cardiac surgery intensive care unit and hybrid operating rooms allow for dedicated and focused care for cardiac patients. Our institute is recognized nationally for clinical excellence , including U.S. News & World Report honors and accreditations for our ventricular assist device program, chest pain center and catheterization lab. Acting as a valued clinical trial site, CVI patients receive cutting-edge care locally, offering access to innovative and minimally invasive procedures close to home. To learn more, visit CarilionClinic.org.

    Attachments

    • Philips Azurion
    • Carilion Cardiovascular Institute
    • Philips Azurion EP


    Primary Logo

    Get the next $PHG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PHG

    DatePrice TargetRatingAnalyst
    12/17/2025Sector Perform
    RBC Capital Mkts
    2/25/2025Neutral → Outperform
    Exane BNP Paribas
    2/20/2025Neutral → Buy
    UBS
    10/29/2024Underperform → Hold
    Jefferies
    5/13/2024Mkt Perform → Outperform
    Bernstein
    5/7/2024Underperform → Neutral
    Exane BNP Paribas
    4/30/2024Sell → Neutral
    UBS
    4/30/2024Underweight → Neutral
    JP Morgan
    More analyst ratings

    $PHG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair

    March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that

    3/26/26 9:10:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips launches IntraSight Plus to simplify coronary interventions and advance precision care

    March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, has announced the launch of its intuitive interventional guidance platform, IntraSight Plus, which is cleared for clinical use in the USA and Europe. With CE marking and FDA 510(k) c

    3/25/26 5:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant

    March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips' platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips' innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically underserved communities. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it ranked No. 1 among medical technology companies in the

    3/24/26 4:30:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Philips

    RBC Capital Mkts initiated coverage of Philips with a rating of Sector Perform

    12/17/25 9:26:42 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips upgraded by Exane BNP Paribas

    Exane BNP Paribas upgraded Philips from Neutral to Outperform

    2/25/25 7:12:36 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips upgraded by UBS

    UBS upgraded Philips from Neutral to Buy

    2/20/25 7:05:01 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    SEC Filings

    View All

    SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

    6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    3/30/26 11:06:16 AM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

    6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    3/30/26 11:02:45 AM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form 20-F filed by Koninklijke Philips N.V. NY Registry Shares

    20-F - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    2/19/26 6:40:43 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Leadership Updates

    Live Leadership Updates

    View All

    Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

    March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips' Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO. The Supervisory Board wil

    3/23/26 4:30:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips proposes to re-appoint CEO Roy Jakobs

    February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board's recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. "Roy Jakobs has demonstrated clear leadership, strong execution

    2/10/26 12:55:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    New AI Rollouts Signal Shift From Hype to Healthcare Reality

    USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead. However, there is hope on the horizon to alleviate some of these burdens, coming from the rise of AI in healthcare, as the new tech is proving it can improve diagnostic accuracies, drug discoveries, and administration work flow. Healthcare leaders are already reporting benefits, including reduced clinician workloads through voice-based AI tools and the use of AI agents to boost efficiency and support smarter care delivery. Behind the scenes, the tech is b

    6/24/25 9:45:00 AM ET
    $LLY
    $PHG
    $PLTR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Electronics
    Computer Software: Prepackaged Software

    $PHG
    Financials

    Live finance-specific insights

    View All

    Philips convenes the Annual General Meeting of Shareholders 2026

    March 23, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.Proposal to re-appoint Roy Jakobs (Dutch/German, 1974) as President/CEO and Chairman and memb

    3/23/26 5:30:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Emergency Care Holdings Acquires Philips Emergency Care Business, Launching Global Emergency Care Platform

    Transaction establishes a scalable platform positioned for consolidation and growth in a $26B global emergency medical products market Emergency Care Holdings (ECH), a platform backed by Bridgefield Capital, today announced the completion of its acquisition of the Philips Emergency Care business from Koninklijke Philips N.V. (NYSE:PHG). The business will operate as Heartstream and continue to market select products under a Philips brand license. The acquisition represents the launch of ECH's global platform strategy focused on building a leading portfolio of emergency medical technology companies serving the pre-hospital care market. The emergency medical products sector exceeds $26 bil

    1/14/26 10:31:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips continues momentum; delivers strong order intake, step-up in sales growth and margin expansion

    November 4, 2025Q3 2025 Group Highlights Comparable order intake growth 8%Group sales amounted to EUR 4.3 billion, reflecting 3% increase in comparable salesIncome from operations was EUR 330 millionAdjusted EBITA margin increased by 50 basis points to 12.3% of salesOperating cash flow of EUR 327 million, with a free cash flow of EUR 172 millionPhilips reiterates full-year 2025 outlook, with margin now expected at the upper end of the range Roy Jakobs, CEO of Royal Philips:"In this quarter we maintained our momentum, with AI-powered innovations and long-term partnerships making a real difference for patients and consumers. We drove strong order intake and accelerated sales growth, with sus

    11/4/25 1:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares

    SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    6/25/24 4:35:57 PM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares (Amendment)

    SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    5/16/24 5:52:57 PM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form SC 13D filed by Koninklijke Philips N.V. NY Registry Shares

    SC 13D - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    8/23/23 12:44:28 PM ET
    $PHG
    Medical Electronics
    Health Care